Central Nervous System (CNS) Therapeutic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Type (Neurovascular Diseases, Degenerative Disorders, Mental Health, Trauma, Others); Drug Type (Analgesics, Nervous System Drugs, Anesthetics, Anti-Parkinson Drugs, Anti-Epileptics, Others); Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Geography
Report Code: TIPRE00004069 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Central Nervous System (CNS) Therapeutic Market - By Disease Type
1.3.2 Central Nervous System (CNS) Therapeutic Market - By Drug Type
1.3.3 Central Nervous System (CNS) Therapeutic Market - By Distribution Channel
1.3.4 Central Nervous System (CNS) Therapeutic Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. NEUROVASCULAR DISEASES
7.3.1. Overview
7.3.2. Neurovascular Diseases Market Forecast and Analysis
7.4. DEGENERATIVE DISORDERS
7.4.1. Overview
7.4.2. Degenerative Disorders Market Forecast and Analysis
7.5. MENTAL HEALTH
7.5.1. Overview
7.5.2. Mental Health Market Forecast and Analysis
7.6. TRAUMA
7.6.1. Overview
7.6.2. Trauma Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANALGESICS
8.3.1. Overview
8.3.2. Analgesics Market Forecast and Analysis
8.4. NERVOUS SYSTEM DRUGS
8.4.1. Overview
8.4.2. Nervous System Drugs Market Forecast and Analysis
8.5. ANESTHETICS
8.5.1. Overview
8.5.2. Anesthetics Market Forecast and Analysis
8.6. ANTI-PARKINSON DRUGS
8.6.1. Overview
8.6.2. Anti-Parkinson Drugs Market Forecast and Analysis
8.7. ANTI-EPILEPTICS
8.7.1. Overview
8.7.2. Anti-Epileptics Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
10. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Central Nervous System (CNS) Therapeutic Market Overview
10.1.2 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.1.3 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.1.4 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.1.5 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.1.6.1 United States Central Nervous System (CNS) Therapeutic Market
10.1.6.1.1 United States Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.1.2 United States Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.1.3 United States Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.1.6.2 Canada Central Nervous System (CNS) Therapeutic Market
10.1.6.2.1 Canada Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.2.2 Canada Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.2.3 Canada Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.1.6.3 Mexico Central Nervous System (CNS) Therapeutic Market
10.1.6.3.1 Mexico Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.3.2 Mexico Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.3.3 Mexico Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Central Nervous System (CNS) Therapeutic Market Overview
10.2.2 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.2.3 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Central Nervous System (CNS) Therapeutic Market
10.2.6.1.1 Germany Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.1.2 Germany Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.1.3 Germany Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.2 France Central Nervous System (CNS) Therapeutic Market
10.2.6.2.1 France Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.2.2 France Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.2.3 France Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.3 Italy Central Nervous System (CNS) Therapeutic Market
10.2.6.3.1 Italy Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.3.2 Italy Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.3.3 Italy Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.4 Spain Central Nervous System (CNS) Therapeutic Market
10.2.6.4.1 Spain Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.4.2 Spain Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.4.3 Spain Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.5 United Kingdom Central Nervous System (CNS) Therapeutic Market
10.2.6.5.1 United Kingdom Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.5.2 United Kingdom Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.5.3 United Kingdom Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.6 Rest of Europe Central Nervous System (CNS) Therapeutic Market
10.2.6.6.1 Rest of Europe Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.6.2 Rest of Europe Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.6.3 Rest of Europe Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Overview
10.3.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.3.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Central Nervous System (CNS) Therapeutic Market
10.3.6.1.1 Australia Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.1.2 Australia Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.1.3 Australia Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.2 China Central Nervous System (CNS) Therapeutic Market
10.3.6.2.1 China Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.2.2 China Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.2.3 China Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.3 India Central Nervous System (CNS) Therapeutic Market
10.3.6.3.1 India Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.3.2 India Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.3.3 India Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.4 Japan Central Nervous System (CNS) Therapeutic Market
10.3.6.4.1 Japan Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.4.2 Japan Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.4.3 Japan Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.5 South Korea Central Nervous System (CNS) Therapeutic Market
10.3.6.5.1 South Korea Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.5.2 South Korea Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.5.3 South Korea Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market
10.3.6.6.1 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.6.2 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.6.3 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Overview
10.4.2 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.4.3 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Central Nervous System (CNS) Therapeutic Market
10.4.6.1.1 South Africa Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.1.2 South Africa Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.1.3 South Africa Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Market
10.4.6.2.1 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.2.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.2.3 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.3 U.A.E Central Nervous System (CNS) Therapeutic Market
10.4.6.3.1 U.A.E Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.3.2 U.A.E Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.3.3 U.A.E Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market
10.4.6.4.1 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.4.2 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.4.3 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Central Nervous System (CNS) Therapeutic Market Overview
10.5.2 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.5.3 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Central Nervous System (CNS) Therapeutic Market
10.5.6.1.1 Brazil Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.1.2 Brazil Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.1.3 Brazil Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5.6.2 Argentina Central Nervous System (CNS) Therapeutic Market
10.5.6.2.1 Argentina Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.2.2 Argentina Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.2.3 Argentina Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5.6.3 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market
10.5.6.3.1 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.3.2 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.3.3 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET, KEY COMPANY PROFILES
12.1. LILLY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. OTSUKA PHARMACEUTICAL CO., LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOGEN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK SHARP AND DOHME CORP
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON SERVICES, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Central Nervous System (CNS) Therapeutic Market - By Disease Type
1.3.2 Central Nervous System (CNS) Therapeutic Market - By Drug Type
1.3.3 Central Nervous System (CNS) Therapeutic Market - By Distribution Channel
1.3.4 Central Nervous System (CNS) Therapeutic Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS
5. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - GLOBAL MARKET ANALYSIS
6.1. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC - GLOBAL MARKET OVERVIEW
6.2. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. NEUROVASCULAR DISEASES
7.3.1. Overview
7.3.2. Neurovascular Diseases Market Forecast and Analysis
7.4. DEGENERATIVE DISORDERS
7.4.1. Overview
7.4.2. Degenerative Disorders Market Forecast and Analysis
7.5. MENTAL HEALTH
7.5.1. Overview
7.5.2. Mental Health Market Forecast and Analysis
7.6. TRAUMA
7.6.1. Overview
7.6.2. Trauma Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DRUG TYPE
8.1. OVERVIEW
8.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
8.3. ANALGESICS
8.3.1. Overview
8.3.2. Analgesics Market Forecast and Analysis
8.4. NERVOUS SYSTEM DRUGS
8.4.1. Overview
8.4.2. Nervous System Drugs Market Forecast and Analysis
8.5. ANESTHETICS
8.5.1. Overview
8.5.2. Anesthetics Market Forecast and Analysis
8.6. ANTI-PARKINSON DRUGS
8.6.1. Overview
8.6.2. Anti-Parkinson Drugs Market Forecast and Analysis
8.7. ANTI-EPILEPTICS
8.7.1. Overview
8.7.2. Anti-Epileptics Market Forecast and Analysis
8.8. OTHERS
8.8.1. Overview
8.8.2. Others Market Forecast and Analysis
9. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET - REVENUE AND FORECASTS TO 2028 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
10. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Central Nervous System (CNS) Therapeutic Market Overview
10.1.2 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.1.3 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.1.4 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.1.5 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.1.6.1 United States Central Nervous System (CNS) Therapeutic Market
10.1.6.1.1 United States Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.1.2 United States Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.1.3 United States Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.1.6.2 Canada Central Nervous System (CNS) Therapeutic Market
10.1.6.2.1 Canada Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.2.2 Canada Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.2.3 Canada Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.1.6.3 Mexico Central Nervous System (CNS) Therapeutic Market
10.1.6.3.1 Mexico Central Nervous System (CNS) Therapeutic Market by Disease Type
10.1.6.3.2 Mexico Central Nervous System (CNS) Therapeutic Market by Drug Type
10.1.6.3.3 Mexico Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Central Nervous System (CNS) Therapeutic Market Overview
10.2.2 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.2.3 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.2.5 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Central Nervous System (CNS) Therapeutic Market
10.2.6.1.1 Germany Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.1.2 Germany Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.1.3 Germany Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.2 France Central Nervous System (CNS) Therapeutic Market
10.2.6.2.1 France Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.2.2 France Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.2.3 France Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.3 Italy Central Nervous System (CNS) Therapeutic Market
10.2.6.3.1 Italy Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.3.2 Italy Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.3.3 Italy Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.4 Spain Central Nervous System (CNS) Therapeutic Market
10.2.6.4.1 Spain Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.4.2 Spain Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.4.3 Spain Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.5 United Kingdom Central Nervous System (CNS) Therapeutic Market
10.2.6.5.1 United Kingdom Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.5.2 United Kingdom Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.5.3 United Kingdom Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.2.6.6 Rest of Europe Central Nervous System (CNS) Therapeutic Market
10.2.6.6.1 Rest of Europe Central Nervous System (CNS) Therapeutic Market by Disease Type
10.2.6.6.2 Rest of Europe Central Nervous System (CNS) Therapeutic Market by Drug Type
10.2.6.6.3 Rest of Europe Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Overview
10.3.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.3.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.3.5 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Central Nervous System (CNS) Therapeutic Market
10.3.6.1.1 Australia Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.1.2 Australia Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.1.3 Australia Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.2 China Central Nervous System (CNS) Therapeutic Market
10.3.6.2.1 China Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.2.2 China Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.2.3 China Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.3 India Central Nervous System (CNS) Therapeutic Market
10.3.6.3.1 India Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.3.2 India Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.3.3 India Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.4 Japan Central Nervous System (CNS) Therapeutic Market
10.3.6.4.1 Japan Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.4.2 Japan Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.4.3 Japan Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.5 South Korea Central Nervous System (CNS) Therapeutic Market
10.3.6.5.1 South Korea Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.5.2 South Korea Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.5.3 South Korea Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market
10.3.6.6.1 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market by Disease Type
10.3.6.6.2 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market by Drug Type
10.3.6.6.3 Rest of Asia-Pacific Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Overview
10.4.2 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.4.3 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.4.5 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Central Nervous System (CNS) Therapeutic Market
10.4.6.1.1 South Africa Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.1.2 South Africa Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.1.3 South Africa Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Market
10.4.6.2.1 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.2.2 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.2.3 Saudi Arabia Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.3 U.A.E Central Nervous System (CNS) Therapeutic Market
10.4.6.3.1 U.A.E Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.3.2 U.A.E Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.3.3 U.A.E Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market
10.4.6.4.1 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market by Disease Type
10.4.6.4.2 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market by Drug Type
10.4.6.4.3 Rest of Middle East and Africa Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Central Nervous System (CNS) Therapeutic Market Overview
10.5.2 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis
10.5.3 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Drug Type
10.5.5 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Central Nervous System (CNS) Therapeutic Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Central Nervous System (CNS) Therapeutic Market
10.5.6.1.1 Brazil Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.1.2 Brazil Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.1.3 Brazil Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5.6.2 Argentina Central Nervous System (CNS) Therapeutic Market
10.5.6.2.1 Argentina Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.2.2 Argentina Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.2.3 Argentina Central Nervous System (CNS) Therapeutic Market by Distribution Channel
10.5.6.3 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market
10.5.6.3.1 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market by Disease Type
10.5.6.3.2 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market by Drug Type
10.5.6.3.3 Rest of South and Central America Central Nervous System (CNS) Therapeutic Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CENTRAL NERVOUS SYSTEM (CNS) THERAPEUTIC MARKET, KEY COMPANY PROFILES
12.1. LILLY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. PFIZER INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. OTSUKA PHARMACEUTICAL CO., LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIOGEN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK SHARP AND DOHME CORP
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ASTRAZENECA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. NOVARTIS AG
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TAKEDA PHARMACEUTICAL COMPANY LIMITED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON SERVICES, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
- Lilly
- Pfizer Inc.
- Otsuka Pharmaceutical Co., Ltd
- Biogen
- Merck Sharp and Dohme Corp
- AstraZeneca
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd
- Johnson and Johnson Services, Inc
- GlaxoSmithKline Plc
- Cipla Inc.
- Dr. Reddy's Laboratories Ltd
- Abbott
- Alkem Labs
- Lilly
- Pfizer Inc.
- Otsuka Pharmaceutical Co., Ltd
- Biogen
- Merck Sharp and Dohme Corp
- AstraZeneca
- Novartis AG
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd
- Johnson and Johnson Services, Inc
- GlaxoSmithKline Plc
- Cipla Inc.
- Dr. Reddy's Laboratories Ltd
- Abbott
- Alkem Labs
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount